Effect of hormone replacement therapy on markers of bone metabolism in RA.
Open Access
- 1 November 1993
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 52 (11) , 835-836
- https://doi.org/10.1136/ard.52.11.835-b
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1993
- Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradationClinical Chemistry, 1993
- Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis.Annals of the Rheumatic Diseases, 1993
- The effect of the menopause and hormone replacement therapy on serum carboxyterminal propeptide of type I collagenOsteoporosis International, 1993
- Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myelomaBritish Journal of Cancer, 1992
- Radioimmunoassay of the carboxyterminal propeptide of human type I procollagenClinical Chemistry, 1990
- The pathophysiology of peri‐ and postmenopausal bone lossBJOG: An International Journal of Obstetrics and Gynaecology, 1989